Biofortuna to Provide HLA Kits for Lab901's PCR-Based Diagnostic Platform | GenomeWeb

Lab901 and Biofortuna said this week that they will collaborate on the development of an automated PCR-based diagnostic system for the rapid detection of celiac disease and other diseases related to human leukocyte antigen status.

Lab901, based in Edinburgh, UK, said that it will optimize its ScreenTape PCR diagnostics platform for use with Liverpool, UK-based Biofortuna’s multiplex PCR diagnostics kits for the detection of celiac disease and other HLA-related diseases such as reactive arthritis, diabetes, and drug hypersensitivity.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.